cysteamine has been researched along with oxidopamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, KL; Haroutunian, V; Santucci, AC | 1 |
| Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
| Badrinarayanan, S; Boivin, L; Bousquet, M; Chabrat, A; Charest, J; Cicchetti, F; Cisbani, G; Drouin-Ouellet, J; Gibrat, C; Lagacé, M; Lavallée-Bourget, MH; Lebel, M; Lévesque, M; Saint-Pierre, M | 1 |
| Chang, JC; Chen, YH; Cheng, FC; Chuang, CS; Kuo, SJ; Liu, CS; Liu, KH; Su, HL; Wei, YH; Wu, SL | 1 |
4 other study(ies) available for cysteamine and oxidopamine
| Article | Year |
|---|---|
Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Avoidance Learning; Cerebral Cortex; Choline O-Acetyltransferase; Corticotropin-Releasing Hormone; Cysteamine; Disease Models, Animal; Dopamine; Hydroxydopamines; Ibotenic Acid; Male; Norepinephrine; Oxidopamine; Physostigmine; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Somatostatin | 1990 |
FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action.
Topics: Aging; Animals; Behavior, Animal; Benzamides; Brain; Cysteamine; Fenclonine; Male; Memory; Nootropic Agents; Oxidopamine; Piperazines; Raphe Nuclei; Rats; Rats, Inbred F344; Receptors, Cholinergic; Serotonin; Somatostatin | 1996 |
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Astrocytes; Cell Line; Cells, Cultured; Corpus Striatum; Cystamine; Cysteamine; Disease Models, Animal; Dopaminergic Neurons; Indans; Lipopolysaccharides; Male; Mice, Inbred C57BL; Neurites; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders | 2015 |
Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity.
Topics: Animals; Calbindins; Cell Transplantation; Cysteamine; Dopaminergic Neurons; Female; Humans; Mitochondria; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Peptides; Rats; Rats, Sprague-Dawley; Substantia Nigra; Transplantation, Heterologous; Transplantation, Homologous | 2016 |